These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23243001)

  • 1. Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy-causing mutations.
    Simon DN; Domaradzki T; Hofmann WA; Wilson KL
    Mol Biol Cell; 2013 Feb; 24(3):342-50. PubMed ID: 23243001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamin A/C mutants disturb sumo1 localization and sumoylation in vitro and in vivo.
    Boudreau É; Labib S; Bertrand AT; Decostre V; Bolongo PM; Sylvius N; Bonne G; Tesson F
    PLoS One; 2012; 7(9):e45918. PubMed ID: 23029315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD).
    Magracheva E; Kozlov S; Stewart CL; Wlodawer A; Zdanov A
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):665-70. PubMed ID: 19574635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin A reassembly at the end of mitosis is regulated by its SUMO-interacting motif.
    Moriuchi T; Kuroda M; Kusumoto F; Osumi T; Hirose F
    Exp Cell Res; 2016 Mar; 342(1):83-94. PubMed ID: 26921507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct actin binding to A- and B-type lamin tails and actin filament bundling by the lamin A tail.
    Simon DN; Zastrow MS; Wilson KL
    Nucleus; 2010; 1(3):264-72. PubMed ID: 21327074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells.
    Bechert K; Lagos-Quintana M; Harborth J; Weber K; Osborn M
    Exp Cell Res; 2003 May; 286(1):75-86. PubMed ID: 12729796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
    Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
    J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
    Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
    Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.
    Impens F; Radoshevich L; Cossart P; Ribet D
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12432-7. PubMed ID: 25114211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies.
    Zhang YQ; Sarge KD
    J Cell Biol; 2008 Jul; 182(1):35-9. PubMed ID: 18606848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural instability of lamin A tail domain modulates its assembly and higher order function in Emery-Dreifuss muscular dystrophy.
    Mio M; Sugiki T; Matsuda C; Mitsuhashi H; Kojima C; Chan SY; Hayashi YK; Mio K
    Biochem Biophys Res Commun; 2019 Apr; 512(1):22-28. PubMed ID: 30853177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.
    Subramanyam L; Simha V; Garg A
    Clin Genet; 2010 Jul; 78(1):66-73. PubMed ID: 20041886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of SREBP1 depends on its interaction with the C-terminal region of wild-type and disease related A-type lamins.
    Duband-Goulet I; Woerner S; Gasparini S; Attanda W; Kondé E; Tellier-Lebègue C; Craescu CT; Gombault A; Roussel P; Vadrot N; Vicart P; Ostlund C; Worman HJ; Zinn-Justin S; Buendia B
    Exp Cell Res; 2011 Dec; 317(20):2800-13. PubMed ID: 21993218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.
    Speckman RA; Garg A; Du F; Bennett L; Veile R; Arioglu E; Taylor SI; Lovett M; Bowcock AM
    Am J Hum Genet; 2000 Apr; 66(4):1192-8. PubMed ID: 10739751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico investigation of molecular mechanism of laminopathy caused by a point mutation (R482W) in lamin A/C protein.
    Rajendran V; Purohit R; Sethumadhavan R
    Amino Acids; 2012 Aug; 43(2):603-15. PubMed ID: 21989830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.
    Vadrot N; Duband-Goulet I; Cabet E; Attanda W; Barateau A; Vicart P; Gerbal F; Briand N; Vigouroux C; Oldenburg AR; Lund EG; Collas P; Buendia B
    Hum Mol Genet; 2015 Apr; 24(7):2096-109. PubMed ID: 25524705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
    Favreau C; Dubosclard E; Ostlund C; Vigouroux C; Capeau J; Wehnert M; Higuet D; Worman HJ; Courvalin JC; Buendia B
    Exp Cell Res; 2003 Jan; 282(1):14-23. PubMed ID: 12490190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).
    Lanktree M; Cao H; Rabkin SW; Hanna A; Hegele RA
    Clin Genet; 2007 Feb; 71(2):183-6. PubMed ID: 17250669
    [No Abstract]   [Full Text] [Related]  

  • 20. SUMO1 Modification Facilitates Avibirnavirus Replication by Stabilizing Polymerase VP1.
    Wu H; Yang H; Ji G; Zheng T; Zhang Y; Deng T; Zheng X; Zhou J; Hu B
    J Virol; 2019 May; 93(10):. PubMed ID: 30842328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.